Bak Foong protects dopaminergic neurons against MPTP‐induced neurotoxicity by its anti‐apoptotic activity

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cell Biology International

• Publication date

  2008-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cellbi.2007.08.016PMID 17920944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Animal Models of Action Tremor

  2008cited by this paper
• Anti‐apoptotic activity of Bak Foong Pills and its ingredients on 6‐hydroxydopamine‐induced neurotoxicity in PC12 cells

  2005cited by this paper
• Neuroprotective effects of Bak Foong Pill in 1-methyl-4-phenyl-1,2,3,6-tetrahyrdropyridine (MPTP)-induced Parkinson's disease model mice.

  2004cited by this paper
• Cardiovascular protective effects of traditional Chinese medicine bak foong pills in spontaneously hypertensive rats.

  2003cited by this paper
• Evidence for generation of oxidative stress in brain by MPTP: in vitro and in Research report

  2003cited by this paper
• Effects of Bak Foong Pill on blood coagulation and platelet aggregation.

  2003cited by this paper
• Effect of Bak Foong pills on enhancing dopamine release from the amygdala of female rats.

  2003cited by this paper
• Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.

  2003cited by this paper
• MPTP: insights into parkinsonian neurodegeneration.

  2002influential reference
• Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

  2001cited by this paper
• UPREGULATION OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR EXPRESSION BY OESTROGEN AND BAK FOONG PILL IN MOUSE UTERI

  2001cited by this paper
• Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

  2001cited by this paper
• Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease.

  2000cited by this paper
• Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons.

  2000cited by this paper
• Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease.

  2000cited by this paper
• Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990

  1999cited by this paper
• Dopamine transporters and neuronal injury.

  1999cited by this paper
• The female sex hormone oestrogen as a neuroprotectant.

  1999cited by this paper
• Mechanisms of MPTP toxicity.

  1998cited by this paper
• A fluorescent double‐labeling method to detect and confirm apoptotic nuclei in parkinson's disease

  1998cited by this paper
• Recent biochemical studies of the dopamine transporter--a CNS drug target.

  1998cited by this paper
• Postmenopausal estrogen use and Parkinson's disease with and without dementia

  1998influential reference
• Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.

  1998influential reference
• Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.

  1997cited by this paper
• Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice.

  1996cited by this paper
• Bax protein-like immunoreactivity in primary sensory and hypothalamic neurons of adult rats.

  1996cited by this paper
• Manganese and 1-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine induce apoptosis in PC12 cells☆

  1996cited by this paper
• Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice.

  1996influential reference
• Neuronal antioxidant system and MPTP-induced oxidative stress in the striatum and brain stem of the rat.

  1995cited by this paper
• Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1995cited by this paper
• Effects of 1‐Methyl‐4‐Phenylpyridinium on Isolated Rat Brain Mitochondria: Evidence for a Primary Involvement of Energy Depletion

  1994cited by this paper
• Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat.

  1994cited by this paper
• Complex I Inhibitors Induce Dose‐Dependent Apoptosis in PC12 Cells: Relevance to Parkinson's Disease

  1994cited by this paper
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

  1993cited by this paper
• Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium

  1993cited by this paper
• Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons.

  1991cited by this paper
• Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.

  1991cited by this paper
• Oxygen free radicals and Parkinson's disease.

  1991cited by this paper
• An examination of male‐female differences in progression and mortality of Parkinson's disease

  1990cited by this paper
• Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.

  1985cited by this paper
• Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

  1985cited by this paper
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

  1985cited by this paper
• Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

  1984cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• [19] Cell cycle analysis by flow cytometry

  1979cited by this paper
• Cell cycle analysis by flow cytometry.

  1979cited by this paper

• The assessment of possible gender-related effect of endogenous striatal alpha-tocopherol level on MPTP neurotoxicity in mice

  2020influential citation
• The Benefits of Natural Products for Neurodegenerative Diseases

  2016cites this paper
• Plant-Derived Natural Products for Parkinson's Disease Therapy.

  2016cites this paper
• Possible Anti-Parkinson’s Disease Therapeutics From Nature: A Review

  2015cites this paper
• Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?

  2012cites this paper
• Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.

  2012cites this paper
• Preventive role of PD‐1 on MPTP‐induced dopamine depletion in mice

  2010cites this paper
• Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.

  2009cites this paper
• Proteomic analysis of cellular models of neurodegeneration and mitochondrial dysfunction

  2009cites this paper